School of Medicine
Showing 11-20 of 74 Results
Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Dermatology at the Palo Alto Veterans Affairs Health Care Center
Current Research and Scholarly Interests My research interests focus on all aspects of systemic sclerosis. I am currently involved in clinical, translational, and epidemiologic research in these areas, and dedicate a substantial portion of my research time to investigator-initiated and multi-center clinical trials of novel therapeutics for the treatment of systemic sclerosis.
Melody Pei-Shien Chung MD
Postdoctoral Medical Fellow, Immunology and Rheumatology
Bio Melody Chung, MD is currently a clinical research fellow in the Department of Rheumatology/Immunology at Stanford University under the mentorship of Dr. Lorinda Chung and a Masters student in the Epidemiology and Clinical Research program administered through Stanford's Department of Health Research and Policy.
Professor of Pathology and of Medicine (Immunology and Rheumatology)
Current Research and Scholarly Interests Dendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.
Robert Michael Fairchild
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
Current Research and Scholarly Interests Dr. Fairchild?s research interests center on novel applications of ultrasonography in rheumatologic disease. Current active research endeavors include using ultrasound 1) to evaluate articular and soft tissue manifestations of systemic sclerosis, 2) to screen, detect and monitor of connective tissue disease associated interstitial lung disease, 3) and to examine the incidence of immune checkpoint inhibitor related adverse events and inflammatory arthritis.
C. Garrison Fathman
Professor of Medicine (Immunology and Rheumatology), Emeritus
Current Research and Scholarly Interests My lab of molecular and cellular immunology is interested in research in the general field of T cell activation and autoimmunity. We have identified and characterized a gene (GRAIL) that seems to control regulatory T cell (Treg) responsiveness by inhibiting the Treg IL-2 receptor desensitization. We have characterized a gene (Deaf1) that plays a major role in peripheral tolerance in T1D. Using PBC gene expression, we have provisionally identified a signature of risk and progression in T1D.
James W. Raitt M.D. Professor, Emeritus
Current Research and Scholarly Interests Clinical trials and interventions in the rheumatic diseases including Rheumatoid Arthritis,Systemic Lupus Erythematosus, Systemic Sclerosis, Osteoarthritis.